GoldsmithLA. Tyrosinaemia and related disorders. In: StanburyJRWyngaardenJBFredricksonDSGoldsteinJLBrownMS, eds. Metabolic basis of inherited disease. New York: McGraw Hill, 1983: 287–99
2.
BurnsRP. Soluble tyrosine aminotransferase deficiency: An unusual cause of corneal ulcers. Am J Ophthalmol1972; 73: 400–402
3.
BeinfangDCKuwabaraTPueschelS. The Richner-Hanhart Syndrome. Arch Ophthalmol1976; 94: 1133–7
BurnsRPGipsonIKMurrayMJ. Keratopathy in tyrosinaemia. Birth Defects Original Article Series 1976, xii, 169–80. The National Foundation — March of Dimes. New York: Alan R Liss
6.
SimellOTakkiK. Raised plasma ornithine and gyrate atrophy of the choroid and retina. Lancet1973; i: 1031–3
7.
TakkiK. Differential diagnosis between the primary total choroidal vascular atrophies. Br J Ophthalmol1974; 58: 24–33
8.
McCullochCMarlissEB. Gyrate atrophy of the choroid and retina with hyperornithinaemia. Am J Ophthalmol1980; 80: 1047–57
9.
ErochJMO'DonnellJWilliamsRAEssockEA. Retinal boundaries and visual function in gyrate atrophy. Arch Ophthalmol1984; 102: 1314–16
10.
SipilaISimellORapolaJSainioKTuuteriL. Gyrate atrophy of the choroid and retina with hyperornithinaemia: Tubular aggregates and type 2 fiber atrophy in muscle. Neurology1979: 29; 996–1005
11.
WeleberRGKennawayNGBuistNRM. Vitamin B6 in management of gyrate atrophy of choroid and retinal. Lancet1978: ii;1213
12.
ValleDWalserMBrusilowSWKaiser-KupferM. Gyrate atrophy of the choroid and retina: Amino acid metabolism and correction of hyperornithinaemia with an arginine-deficient diet. J Clin Invest1980; 65: 371–8
13.
TadaKSaitoTHayasakaSMizunoK. Hyperornithinaemia with gyrate atrophy: Pathophysiology and treatment. J Inherited Metab Dis1983; 6: 105–6
14.
SaltHBWolffOHLloydJKFosbrookeASCameronAHHubbleDV. On having no beta-lipoprotein: A syndrome comprising a-beta-lipoproteinaemia, acanthocytosis and steatorrhoea. Lancet1960: ii; 324–9
15.
RungePMullerDPRMcAllisterJCalverDLloydJKTaylorD. Oral vitamin E supplements can prevent the retinopathy of a-beta-lipoproteinaemia. Br J Ophthalmol1986: 70; 166–77
16.
MullerDPRLloydJKBirdAC. Long-term management of a-beta-lipoproteinaemia: Possible role for vitamin E. Arch Dis Child1977: 52; 209–14
17.
SchutgensRBHHeymansHSAWandersRJABoschHvbTagerJM. Peroxisomal disorders: A newly recognised group of genetic diseases. Eur J Pediatr1986: 144; 430–40
18.
GarnerAFielderARPrimavesiRStevensA. Tapetoretinal degeneration in the cerebro-hepato-renal (Zellweger's) syndrome. Br J Ophthalmol1982: 66; 422–31
19.
LawsonAMMadiganMJShortlandDClaytonPT. Rapid diagnosis of Zellweger's syndrome and infantile Refsum's disease by fast atom bombardment — mass spectrometry of urine bile salts. Clin Chem Acta1986; 161: 221–31
20.
HajraAKDattaNSJacksonLG, Prenatal diagnosis of Zellweger cerebrotepatorenal syndrome Getter). N Engl J Med1985: 312; 445–6
21.
MuddSHSkovbyFLevyHL, The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet1985; 37: 1–31
22.
MuddSH. Vascular disease and homocysteine metabolism. N Engl J Med1985; 313: 751–3
23.
BoersGHJSmalsAGHTrijbelsFJM, Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Eng J Med1985: 313; 709–15